EFG Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

EFG Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,514	Closed	-$2.38M	–	202
2023 Q4	$2.38M	Buy	7,514 +1,605	+27%	+$312K	0.45%	83
2023 Q3	$1,000K	Sell	5,909 -565	-9%	-$106K	0.24%	143
2023 Q2	$1.4M	Sell	6,474 -384	-6%	-$82.3K	0.3%	117
2023 Q1	$1.25M	Buy	6,858 +987	+17%	+$189K	0.28%	132
2022 Q4	$1.14M	Sell	5,871 -197	-3%	-$42.2K	0.26%	142
2022 Q3	$1.36M	Buy	+6,068	New	+$1.23M	0.32%	112

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

EFG Asset Management's KRTX Position: Q1 2024 in Review

EFG Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 7,514 shares — an estimated $2.38M sold.

EFG Asset Management first reported a position in KRTX in Q3 2022 and held it in 6 quarters. The position peaked at $2.38M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

EFG Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
EFG Asset Management sold 7,514 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.38M.
EFG Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
EFG Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $2.38M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on EFG Asset Management's 13F filing for Q1 2024, filed 13 May 2024.